Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
26 hedge funds and large institutions have $4.06M invested in Fibrocell Science Inc. in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
4% more funds holding
Funds holding: 25 → 26 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less capital invested
Capital invested by funds: $5.78M → $4.06M (-$1.73M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$160K |
| 2 |
Renaissance Technologies
New York
|
+$137K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$84.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$59.9K |
| 5 |
Morgan Stanley
New York
|
+$35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
-$9.6K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$8K |
| 3 |
VF
Virtu Financial
New York
|
-$7.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.28K |
| 5 |
ADL
Asset Dedication LLC
San Francisco,
California
|
-$2K |
FCSC Hedge Fund Activity: Q4 2018 in Review
26 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2018, worth a combined $4.06M — down 30% from $5.78M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FCSC positions and 3 closed out — a net gain of 1 holder — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Oxford Asset Management, adding an estimated $160K. The largest seller was Creative Planning, cutting an estimated $9.6K.
- 26 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2018, up from 25 in Q3 2018.
- Funds reported $4.06M of Fibrocell Science Inc. stock for Q4 2018, down 30% quarter-over-quarter.
- 4 funds opened new Fibrocell Science Inc. positions in Q4 2018 and 3 closed out, a net change of +1 holder.
- The largest Fibrocell Science Inc. buyer in Q4 2018 was Oxford Asset Management, an estimated $160K added.
- The largest Fibrocell Science Inc. seller in Q4 2018 was Creative Planning, an estimated $9.6K sold.
Based on aggregated 13F filings for Q4 2018.